Development of 5-Fluorouracil derivatives as anticancer agents

Area of Science:

• Oncology
• Medicinal Chemistry
• Pharmacology

Background:

• 5-Fluorouracil (5-FU) is a widely used antimetabolite for advanced solid tumors.
• Limitations of 5-FU include low efficacy and high toxicity, necessitating structural modifications.
• Numerous novel 5-FU derivatives have been synthesized to enhance therapeutic outcomes.

Purpose of the Study:

• To review and discuss recent advancements in the development of novel 5-Fluorouracil derivatives.
• To highlight 5-FU derivatives with improved antitumor potency and reduced toxicity.
• To provide an overview of innovative strategies in 5-FU drug development.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of structural modifications and their impact on efficacy and toxicity.
• Discussion of preclinical and clinical data on novel 5-FU derivatives.

Main Results:

• Development of various 5-FU derivatives with enhanced antitumor activity against solid tumors.
• Demonstration of significantly reduced toxicity profiles in novel 5-FU analogs.
• Identification of promising candidates for improved cancer therapy.

Conclusions:

• Novel 5-FU derivatives represent a significant advancement in anticancer drug development.
• These derivatives offer a more effective and safer alternative to conventional 5-FU.
• Further research into 5-FU derivatives holds promise for future cancer treatment strategies.